Bifarcept

• UNSPSC Description:

  Bifarcept is a recombinant antibody of interferon receptor type I (IFN-RI). Bifarcept can bind IFN-β and prolong its serum half-life[1].

• Target Antigen:

  IFNAR

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/bifarcept.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [Bifarcept]

• References & Citations:

  [1]Bilsborough J, et, al. From model to mechanism: lessons of mice and men in the discovery of protein biologicals for the treatment of inflammatory bowel disease. Expert Opin Drug Discov. 2006 Jun;1(1):69-83.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  163796-60-9